Cathepsin D in breast cancer: A tissue marker associated with metastasis

European Journal of Cancer

Volumn 28, Issue 11, 1992, Pages 1780-1783

  Rochefort, Henri ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; TUMOR MARKER;

BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

BREAST NEOPLASMS; CATHEPSIN D; FEMALE; HUMAN; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0026779307     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(92)90003-K     Document Type: Article

References (14)

1. How to use prognostic factors in axillary node-negative breast cancer patients
2. Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications
3. Monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein: characterization and immunodetection in MCF7 cells
4. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells
5. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52K protein
6. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer
7. CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER
8. Cathepsin-D and prognosis in breast cancer
9. Quality control of cathepsin-D measurement by the EORTC receptor study group
10. Prognostic value of total cathepsin D in breast tumours. A possible role in selection of chemoresistant patients
11. Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.
12. Regulation of Cathepsin-D and pS2 Gene Expression by Growth Factors in MCF7 Human Breast Cancer Cells
13. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells
14. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency